Key Insights

Highlights

Success Rate

86% trial completion

Published Results

23 trials with published results (9%)

Research Maturity

108 completed trials (44% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

7.3%

18 terminated out of 246 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

17%

42 trials in Phase 3/4

Results Transparency

21%

23 of 108 completed with results

Key Signals

23 with results86% success18 terminated

Data Visualizations

Phase Distribution

155Total
Not Applicable (74)
Early P 1 (2)
P 1 (15)
P 2 (22)
P 3 (18)
P 4 (24)

Trial Status

Completed108
Unknown57
Recruiting41
Terminated18
Not Yet Recruiting11
Active Not Recruiting5

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 108 completed trials

Clinical Trials (246)

Showing 20 of 20 trials
NCT06983366Recruiting

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

NCT05741697RecruitingPrimary

HFNC in Management of Bronchiectasis Exacerbation

NCT06872892Phase 3RecruitingPrimary

The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

NCT07539571Not ApplicableNot Yet RecruitingPrimary

Telerehabilitation in Patients With Bronchiectasis

NCT00943514RecruitingPrimary

Natural History of Bronchiectasis

NCT06926881Not ApplicableRecruitingPrimary

OLE Therapy With BE Patients in Home Care Study

NCT07523165Phase 2Not Yet RecruitingPrimary

Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis

NCT05846230Phase 2Active Not RecruitingPrimary

Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine

NCT07493629Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

NCT07490704Active Not RecruitingPrimary

Clinical Outcomes of BronchiEctaSis in Taiwan: A Multicenter Prospective Cohort (BEST Study)

NCT06636487Not ApplicableActive Not Recruiting

Expand Pulmonary Rehabilitation to Other Chronic Respiratory Diseases Than COPD

NCT06166056Phase 1RecruitingPrimary

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis

NCT07443124Not ApplicableNot Yet RecruitingPrimary

Simeox 200 US Study

NCT02779478Recruiting

Evaluation Of The Lung Microbiome In NTM Bronchiectasis

NCT07063290Phase 2Completed

COMBO Endoscopy Oropharyngeal Airway in Sedated Fiberoptic Bronchoscopy for Patients: A Simon Two-Stage Trial

NCT06361121Not ApplicableCompletedPrimary

Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy

NCT07274631Recruiting

A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine

NCT06280391Phase 2CompletedPrimary

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

NCT07188675Not ApplicableRecruitingPrimary

Functional Inspiratory Training in Bronchiectasis

NCT07283497Phase 4RecruitingPrimary

Itraconazole Therapy In Bronchiectasis With Airway Mold

Scroll to load more

Research Network

Activity Timeline